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Neuroimmunology of Stress: Skin Takes Center Stage
Petra C. Arck1, Andrzej Slominski2, Theoharis C. Theoharides3, Eva M. J. Peters1 and Ralf Paus4
Like few other organs, the skin is continuously exposed to multiple exogenous and endogenous stressors. 
Superimposed on this is the impact of psychological stress on skin physiology and pathology. Here, we review the 
“brain–skin connection,” which may underlie infl ammatory skin diseases triggered or aggravated by stress, and we 
summarize relevant general principles of skin neuroimmunology and neuroendocrinology. Specifi cally, we portray 
the skin and its appendages as both a prominent target of key stress mediators (such as corticotropin-releasing 
hormone, ACTH, cortisol, catecholamines, prolactin, substance P, and nerve growth factor) and a potent source of 
these prototypic, immunomodulatory mediators of the stress responses. We delineate current views on the role of 
mast cell-dependent neurogenic skin infl ammation and discuss the available evidence that the skin has established 
a fully functional peripheral equivalent of the hypothalamic–pituitary–adrenal axis as an independent, local stress 
response system. To cope with stress-induced oxidative damage, the skin and hair follicles also express melatonin, 
probably the most potent neuroendocrine antioxidant. Lastly, we outline major, as-yet unmet challenges in cutane-
ous stress research, particularly in the study of the cross-talk between peripheral and systemic responses to psy-
chological stress and in the identifi cation of promising molecular targets for therapeutic stress intervention.
Journal of Investigative Dermatology (2006) 126, 1697–1704. doi:10.1038/sj.jid.5700104
Psychological stress is a prevalent 
aspect of life, usually triggered by a 
stimulus (stressor), which induces a 
reaction in the brain (stress percep-
tion). Subsequently, additional physi-
ological systems are activated in the 
body, for example, the immune, endo-
crine, and nervous systems (stress 
response) (Cacioppo et al., 1998). 
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Editor's Note
Several laboratories worldwide have independently 
revealed that our skin is an unexpectedly prominent 
target organ for numerous neuroendocrine, 
neurotrophic, neurotransmitter, and neuropeptide 
signals, which have a profound impact on skin biology 
in health and disease. Even more importantly, they 
have identified the skin as a potent factory for the 
same signals. This, and the recognition that skin 
and nervous system share a common molecular 
syntax and jointly exploit the immune system to 
provide additional signaling and regulatory input, 
are beginning to revolutionize how we think about 
skin. As a consequence, a new specialty — cutaneous 
neuroendocrinology — has emerged that explores 
the “brain–skin connection,” overlapping richly 
with the inseparable fields of skin neurobiology, 
neuroimmunology, and neuropharmacology.
The editors expect cutaneous neuroendocrinology 
to develop into one of the fastest-moving, most 
exciting branches of skin research, impacting the 
course of classical neuro- and psychodermatology, 
and our understanding of pruritus and the role of 
psychoemotional stress in many inflammatory skin 
diseases. It will also influence the development of 
novel (adjuvant?) strategies for the management of skin 
diseases long recognized for their neuronal influences 
(for example, psoriasis, atopic dermatitis, lichen planus, 
and prurigo nodularis). Therefore, we have organized 
two groups of Perspectives articles. The first installment 
sketches the broad outlines of the field by focusing on 
the impact of psychoemotional stress on the skin (Arck 
et al.), on the neurophysiology, neuroimmunology, 
and neuroendocrinology of itch (Steinhoff et al.), and 
on the central role of neurotrophins in skin biology 
(Botchkarev et al.). 
Next month’s issue will complement this with in-depth 
coverage of cholinergic, adrenergic, and peptidergic 
signaling, and the role of melanocortin receptor ligands. 
Ralf Paus
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According to Walter Cannon’s hypoth-
esis, the stress response is an evolu-
tionarily adaptive psychophysiological 
survival mechanism that allows the 
individual to react to an acute stress-
or — for example, a predator — with 
either “fight or flight,” and to react 
to exposure to chronic stress by sav-
ing energy (Cannon, 1914). However, 
stressors have changed, and the present 
connotation of stress does not include 
the survival of the individual based 
on the putative preparedness to fight 
or evade predators, or to save energy. 
Hence, pathophysiological changes 
associated with the stress response are 
misrouted and serve as aggravating or 
triggering factors in the pathogenesis 
of many diseases, for example, inflam-
matory, autoimmune, and allergic dis-
eases (Qiu et al., 1999; Chandler et al., 
2002; Blois et al., 2005). In a general 
sense, the term “stress” is widely used, 
for example in the context of exposure 
to environmental stressors, as depicted 
in Figure 1. In this review, we focus 
predominantly on psychological stress; 
however, as a relationship between 
environmental stress and psychologi-
cal stress is highly suggestive, a discus-
sion of this form of stress has also been 
included (Figure 1).
Systemic response patterns to stress: 
neuro-endocrine-immune circuitry
Activation of neurohormones by psy-
chological stress occurs largely via the 
hypothalamic–pituitary–adrenal (HPA) 
axis, with subsequent upregulation of 
key stress hormones, such as corticotro-
pin-releasing hormone (CRH), ACTH, 
and glucocorticoids (Cacioppo et al., 
1998; Glaser and Kiecolt-Glaser, 2005). 
Via these stress-related hormones, 
accompanied by additional stress 
response mediators such as neuropep-
tides or neurotrophins (Webster, 2002), 
immune responses are profoundly 
altered (Glaser and Kiecolt-Glaser, 
2005). For example, glucocorticoids 
inhibit the production of IL-12, IFN-γ, 
and tumor necrosis factor by antigen-
presenting cells and T helper 1 (Th1) 
cells but upregulate the production 
of IL-4, IL-10, and IL-13 by Th2 cells 
(Wonnacott and Bonneau, 2002). This 
may induce the selective suppression 
of the Th1-mediated cellular immunity 
and trigger a shift toward Th2-mediated 
humoral immunity. It has been postulat-
ed that this Th2 shift may actually pro-
tect the organism from systemic "over-
shooting" with Th1/proinflammatory 
cytokines that have tissue-damaging 
potential (Elenkov et al., 1999). Besides 
such often-cited immunosuppressive 
effects of glucocorticoids, relevant 
examples of proinflammatory actions 
of CRH — which triggers the release of 
glucocorticoids — have recently been 
introduced, for example, in inflamma-
tory arthritis, where both CRH and uro-
cortin have been identified in the joints 
(McEvoy et al., 2001).
Elegant experiments with hypophy-
sectomized rats have further proven the 
effect of additional pituitary hormones 
— for example, prolactin (PRL) — on 
the immune system. In these studies, 
the lack of PRL resulted in abnormali-
ties of the immune system, including 
increased thymic atrophy and lympho-
penia, which could be reversed after 
grafting of syngeneic pituitary (Chikanza 
and Panayi, 1991). Interestingly, elevat-
ed PRL antagonizes apoptosis in thy-
mocytes exposed to glucocorticoids in 
vivo, which suggests that, under condi-
tions of increased glucocorticoids, such 
as during stress, elevated PRL functions 
physiologically to maintain survival and 
function of T lymphocytes (Krishnan et 
al., 2003).
Neurohormonal responses to stress 
also include an activation of the sympa-
thetic nervous system with a subsequent 
increase of catecholamines, a phenom-
enon that has received much less atten-
tion than the stress-triggered activation 
of the HPA axis. For half a century it 
has been known that lymphoid organs 
are prominently innervated by norad-
renergic nerve fibers (Dahlström et al., 
1965), and evidence that has accu-
mulated since then supports the idea 
that the immune system is regulated 
via the sympathetic nervous system 
and catecholamines at the regional, 
local, and systemic levels (Cacioppo 
et al., 1998). For example, lympho-
cytes express adrenergic receptors and 
respond to catecholamine stimulation 
with the development of stress-induced 
lymphocytosis, and distinct changes 
in lymphocyte trafficking, circulation, 
proliferation, and cytokine production 
(Sanders et al., 1997; Dhabhar, 2000).
Besides the classical stress-related 
Figure 1. Brain–skin cross-talk upon exposure to psychological stress or environmental stress factors. 
Upon perception of psychological stress, the central stress response leads to the activation of the 
hypothalamic–pituitary–adrenal axis, which causes the release of corticotropin-releasing hormone 
(CRH), ACTH, and prolactin (PRL). Further, an upregulation of substance P (SP) and calcitonin gene-
related peptide (CGRP) can be observed in the dorsal root ganglia. Such stress response patterns may be 
translated into a skin stress response, including the local production of CRH, ACTH, and glucocorticoids 
(GCs), the release of inflammatory cytokines, and the sprouting of SP+ nerve fibers. In the skin response 
to stress, mast cells occupy a central switchboard position, as they are targets for stress-triggered 
factors as well as effector cells that contribute, for example, to neurogenic inflammation in the skin. 
Environmental factors are also capable of inducing a skin stress response, and this may be signaled to the 
brain, where it affects behavior and leads to an increased vulnerability to additional stress perception. 
NGF, nerve growth factor.
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neurohormones — such as the players 
of the HPA axis (including CRH, ACTH, 
and cortisol), PRL, and catecholamines 
— nerve growth factor (NGF) is now 
recognized as an important parameter 
in stress responses (Aloe et al., 2002). 
Besides its function as an important 
trophic factor for peptidergic and sym-
pathetic neurons and their axon sprout-
ing, NGF is increasingly recognized as 
a potent immunomodulator, promot-
ing cross-talk between neuronal cells, 
glia, and immune cells and facilitat-
ing monocyte/macrophage migration 
through vascular endothelium (Levi-
Montalcini et al., 1996).
Clinical relevance of stress in 
dermatology
The skin is exceptionally well suited to 
serve as a model organ for dissecting 
the complex neuro-endocrine-immune 
circuitry invoked during stress respons-
es, for the following reasons: 
(1) Hardly any other organ is con-
tinuously exposed to such a wide 
range of stressors as the skin, the 
prototypic environmental interface 
organ of vertebrate life; and this 
exposure occurs 24 hours a day dur-
ing our entire lifetime (Figure 1).
(2) A special susceptibility of the 
skin to acute and/or chronic psycho-
logical stress has been described in a 
wide range of skin diseases, includ-
ing pruritus, prurigo nodularis, 
atopic dermatitis, psoriasis, urticaria, 
acne vulgaris, lichen planus, alo-
pecia areata, and telogen effluvium 
(Whitlock, 1976; Zouboulis and 
Böhm, 2004; Hadshiew et al., 2004; 
O’Leary et al., 2004).
(3) Adaptive skin responses to 
acute stress, besides classical auto-
nomic-nervous “stress indicators” 
of the skin such as flushing and 
sweating, include an enhanced skin 
immune function with increased 
intracutaneous extravasation of 
immunocompetent cells (Dhabhar, 
2000) and increased mast-cell 
degranulation (Katsarou-Katsari et 
al., 2001).
(4) The skin and its appendages 
are exquisitely well innervated, and 
their afferent signals to the central 
nervous system are relatively over-
represented in the sensory cortex.
(5) The skin and its append-
ages are capable of generating the 
same mediators that are used dur-
ing systemic stress responses, and 
they have established a fully func-
tional peripheral equivalent of the 
systemic, stress-activated HPA axis 
(Slominski and Wortsman, 2000; Ito 
et al., 2005) (Figure 2).
(6) The course of skin disorders 
(listed in Figure 3) in response to 
stress and/or various stress-modu-
latory psychological or pharmaco-
logical interventions can easily be 
followed macroscopically, and skin 
biopsies for further in-depth histo-
logical, immunological, endocrino-
logical, neurobiological, biochemi-
cal, and molecular analyses can eas-
ily be performed, thus greatly facili-
tating stress research in both humans 
and experimental animals.
The skin has established a fully 
functional peripheral equivalent of the 
hypothalamic–pituitary–adrenal axis
The skin has its own neuroendocrine 
system, which is tightly linked into sys-
temic neuroendocrine axes, probably in 
order to coordinate peripheral respons-
es to stress and to maintain cutaneous 
and global homeostasis (Slominski and 
Wortsman, 2000). These activities are 
organized by the intracutaneous neu-
roendocrine axes, composed chiefly of 
a cutaneous equivalent of the HPA axis 
(Slominski et al., 2002; Slominski et al., 
2005b) (Figures 1 and 2). Recently, a 
fully functional peripheral equivalent of 
the HPA axis could be demonstrated in 
microdissected, organ-cultured human 
scalp hair follicles, which were capable 
of synthesizing cortisol and showing 
fully functional feedback controls (Ito 
et al., 2005).
Strikingly, human skin also express-
es CRH and, additionally, urocortin 
mRNA and protein (Slominski et al., 
2002). Murine skin contains CRH pro-
tein but has not been shown to contain 
CRH mRNA (though it does express 
both transcripts and protein for the 
CRH receptor ligand urocortin). Hence, 
the neural delivery of CRH into the skin 
must also be considered as a possible 
means by which CRH protein can be 
transported into the skin in a highly 
localized fashion (Roloff et al., 1998). 
Most recently, the expression of uro-
cortin II (stresscopin-related peptide) 
mRNA in both human and mouse skin 
could be detected, and corresponding 
receptors for these ligands were also 
identified in skin cells (Pisarchik and 
Slominski, 2001). CRH-like immuno-
reactivity is further present in the dor-
sal horn of the spinal cord and dorsal 
root ganglia (Skofitsch et al., 1985), 
as well as in sympathetic ganglia 
(Merchenthaler et al., 1983). Strikingly, 
acute stress increases the skin content 
of CRH, which may derive from dorsal 
root ganglia (Theoharides et al., 2004).
Mapping of the cutaneous CRH 
Figure 2. Stress mediators and effector cells in the neuro-endocrine-immune environment of the skin. 
Activated mast cells may skew the immune response toward the selective suppression of an adaptive 
T helper 1 (Th1) response and encourage a shift to a Th2 bias, promoting humoral immunity via IL-4. 
On the other hand, mast-cell activation may lead to neurogenic inflammation of the skin and promote 
cellular immunity, accompanied by sprouting of substance P (SP)-positive nerve fibers, endothelial-cell 
activation, vascular leakage, and angiogenesis. Via the release of tryptase by mast cells, proteinase-
activated receptors (PARs) are activated, which additionally enhance neurogenic inflammation and 
vascular leakage. Further, the capability of releasing corticotropin-releasing hormone (CRH) and 
the presence of CRH receptor (CRH-R) allow mast cells to contribute to the activation of the skin 
hypothalamic–pituitary–adrenal (HPA) axis. APC, antigen-presenting cell.
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signaling system in humans revealed 
that the CRH receptor type 1 (CRH-R1) 
is expressed in all major cellular popu-
lations of epidermis, dermis, and sub-
cutis. CRH-R1 appears to be the most 
prevalent isoform of CRH-R, and the 
CRH-R2 gene is expressed solely in 
the dermis and adnexal structures. In 
mouse skin, the CRH-R2 gene and pro-
tein are widely expressed in all cutane-
ous compartments.
The pathophysiological relevance 
of CRH-R1 may be reflected by the 
observation that CRH-R1 is involved in 
stress-induced exacerbation of chronic 
contact dermatitis in rats (Kaneko et 
al., 2003). Interestingly, affected scalp 
skin areas from patients with alopecia 
areata, which may be precipitated by 
psychological stress, show increased 
expression of CRH-R2 around hair fol-
licles (Katsarou-Katsari et al., 2001). 
Furthermore, affected skin areas from 
patients with contact dermatitis and 
chronic urticaria have increased expres-
sion of CRH-R1, as compared with 
normal control skin (TC Theoharides, 
unpublished data). Although the 
importance of CRH-R in the skin stress 
response is highly probable, the func-
tional role of CRH-R expression in 
pathological human skin conditions 
remains to be identified.
Hypothalamic CRH production and 
secretion represent the most proximal 
end of the systemic HPA axis. CRH 
activates CRH-R1 and induces produc-
tion and release of the proopiomela-
nocortin (POMC)-derived peptides 
ACTH, α-melanocyte-stimulating hor-
mone, and β-endorphin in the pitu-
itary gland (Slominski and Wortsman, 
2000). ACTH, in turn, stimulates the 
production and secretion of cortisol 
or corticosterone by the adrenal cor-
tex, which counteract the effect of the 
stressors by suppression of the HPA axis 
through a negative feedback mecha-
nism (Slominski and Wortsman, 2000). 
Mammalian skin expresses POMC and 
produces the POMC-derived peptides 
β-endorphin, ACTH, α-melanocyte-
stimulating hormone, and β-lipocortin. 
The first full demonstration of the cuta-
neous expression of POMC was accom-
plished in mouse skin (Slominski et al., 
1991) and this was followed by insights 
from human skin (Schauer et al., 1994). 
The presence of β-endorphin, ACTH, α-
melanocyte-stimulating hormone, and 
their modified forms in the skin was 
confirmed both by reverse-phase (RP)-
HPLC separation and by liquid-chro-
matography mass spectrometry.
In light of the existence of a local, 
neuroendocrine skin axis, it has been 
proposed that the cutaneous defense 
against stressors is organized similarly 
to the classical HPA axis. Effectors of 
this axis (CRH, urocortin, and POMC 
peptides) are capable of regulating skin 
pigmentary, immune, epidermal, der-
mal, and adnexal systems (see Böhm 
et al., 2006, this issue). In this context, 
environmental challenges such as UV 
light and biological or chemical stress 
(Figure 1) trigger multiple pathways 
involving structuralized or simultaneous 
local production of CRH-related and 
POMC-derived messages (Slominski et 
al., 2005a), possibly to counteract the 
local effects of the environmental stress. 
This complex response would be sus-
ceptible to feedback inhibition by cor-
tisol and/or corticosterone, which are 
produced locally in the skin (Slominski 
et al., 2005a; Ito et al., 2005).
The skin expresses the molecular 
apparatus necessary for the synthesis 
of adrenal and adrenal-like glucocorti-
costeroids. Specifically, production of 
deoxycorticosterone, corticosterone, 
and cortisol was documented in vitro 
(Slominski et al., 2005a). Hence there 
is now experimental evidence that CRH 
triggers a functional cascade structured 
hierarchically along the same algorithm 
as in the classical HPA axis: CRH acti-
vates CRH-R1, stimulates cAMP accu-
mulation, and increases production of 
ACTH with enhanced production of 
cortisol and corticosterone in melano-
cytes, of corticosterone but not cortisol 
in fibroblasts (Slominski et al., 2005b), 
and of ACTH and cortisol in human 
scalp hair follicle epithelium in situ (Ito 
et al., 2005).
The skin expresses additional 
neuroendocrine stress-related signals: 
prolactin, melatonin, catecholamines
This intracutaneous equivalent of the 
systemic HPA axis is complemented 
by additional neuroendocrine activities 
of the skin, whose role in cutaneous 
stress responses remains to be deter-
mined. For example, murine skin and 
hair follicles as well as human scalp 
hair follicles also express PRL, another 
key neuroendocrine signal whose level 
rises sharply during psychological stress 
responses (Sonino et al., 2004).
In addition, the skin and its pilo-
sebaceous units display a complete 
local serotoninergic/melatoninergic 
system (Slominski et al., 2005b), which 
includes the capacity to synthesize 
melatonin (Kobayashi et al., 2005), 
the most effective neurohormonal 
scavenger of reactive oxygen species 
(Fischer and Elsner, 2001). Whether or 
Figure 3. Mast cells: important regulators of 
neurogenic inflammation during stress responses. 
A multitude of mediators, the majority of which 
are released upon stress challenge, act as mast-
cell activators. The activation subsequently 
results in the synthesis or the release of pre-stored 
mediators, which may then trigger a wealth of 
dermatological diseases. CGRP, calcitonin gene-
related peptide; CRH, corticotropin-releasing 
hormone; cysLTs, cysteinyl leukotrienes; 
NGF, nerve growth factor; PACAP, pituitary 
adenylate cyclase-activating polypeptide; PGD2, 
prostaglandin D2; SCF, stem cell factor; SP, 
substance P; TGF-β, transforming growth factor-β; 
TNF, tumor necrosis factor; Ucn, urocortin; VEGF, 
vascular endothelial growth factor; VIP, vasoactive 
intestinal peptide.
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not recently discovered elements of a 
pituitary–thyroid axis, which are also 
expressed in the skin (Slominski et al., 
2002), and the intracutaneous synthesis 
of catecholamines also feed into skin 
responses to psychological stress can 
currently only be speculated on and 
constitutes an important open question 
for future neuroendocrine and neuro-
immunological research into cutaneous 
stress responses.
Skin mast cells and their functional 
role as “switchboards” of neurogenic 
inflammation during stress responses
Human mast cells are activated by a 
plethora of mast-cell secretagogues and 
other mediators (Figure 3) (Theoharides 
and Conti, 2004). This includes the 
stress hormones ACTH and CRH, as 
skin mast cells express five CRH-R1 
isoforms as well as CRH-R2α (Pisarchik 
and Slominski, 2001). Strikingly, 
besides hair follicles, skin mast cells 
may be among the richest sources of 
CRH outside the brain (Kempuraj et al., 
2001). Thus, skin mast cells not only are 
highly sensitive to modulation of their 
activities by classical stress hormones 
but also generate key stress hormones 
(at least CRH) themselves.
Conversely, once mast-cell degran-
ulation has been induced by stress, 
the itch induced by one prototypic 
mast-cell product, histamine, elicits 
tonic sensory stimuli that differ from 
the central nervous system sensa-
tions triggered by pain and stimulates 
distinct cortical regions and brain 
processes (Walter et al., 2005). Thus, 
stress-induced mast-cell degranulation 
in the skin probably has immediate 
and prominent central nervous system 
effects, which may sustain a vicious, 
stress-induced cycle of proinflamma-
tory events (Figures 2 and 3).
Mast-cell activation is well known 
for its key role in allergic and anaphy-
lactic reactions; furthermore, mast 
cells are capable of synthesizing and 
secreting over 50 biologically potent 
molecules, including most cytokines 
(Figure 3). Hence, mast cells may easily 
induce a multitude of tissue effects nec-
essary for the initiation of inflammation 
(Figures 2 and 3), the most prominent 
being vasodilation, vascular endothelial 
molecule expression, and chemoattrac-
tion. In fact, mast cells have now been 
implicated in innate immunity (Galli et 
al., 2005). The vasodilatory, angiogenic, 
proinflammatory, and neurosensitizing 
mediators of mast cells include hista-
mine, heparin, kinins, neuropeptides 
such as vasoactive intestinal peptide, 
and proteases such as chymase and 
tryptase (preformed), as well as che-
moattractants, cytokines, growth fac-
tors, leukotrienes, prostaglandins, nitric 
oxide, stem cell factor, and vascular 
endothelial growth factor (Theoharides 
and Conti, 2004).
The most abundant mast-cell media-
tor is tryptase, which causes microvas-
cular leakage, activation of proteinase-
activated receptors, and inflammation, 
as well as activation of neuropeptide 
precursors and direct proteolytic dam-
age. Mast cells are also particularly rich 
in tumor necrosis factor and IL-6, both 
of which are implicated in inflamma-
tion and could perpetuate local inflam-
matory processes in response to psy-
chological, chemical, mechanical, or 
oxidative stress.
Mast cells are located perivascularly 
in close proximity to neurons, and a 
functional association between mast 
cells and neurons has been reported 
(Arck et al., 2003a). Mast cells could 
also be activated by antidromic nerve 
stimulation, as shown for trigeminal 
or cervical ganglion stimulation that 
may result in neuropeptide secretion 
(Dimitriadou et al., 1991). Substance 
P (SP)-reactive fibers were localized 
close to mast cells (Arck et al., 2003b), 
and release of SP from sensory affer-
ents could stimulate mast-cell secre-
tion in vivo.
In contrast to the degranulation 
typically observed in anaphylactic 
reactions, in which most of the 500 
secretory granules (1,000 nm each in 
diameter) release their contents in an 
explosive manner, mast cells can under-
go secretion of the content of individual 
granules. Mast cells also have the abil-
ity to release some mediators selective-
ly without degranulation. This unique 
phenomenon was described first for 
biogenic amines and recently for IL-6 in 
response to the prototypic inflammatory 
cytokine IL-1; this process involves the 
selective release of IL-6, without hista-
mine or tryptase, through small vesicles 
(50–70 nm each in diameter) (Kandere-
Grzybowska et al., 2003). Such selec-
tive release of mediators could be 
involved in a variety of processes, 
including stress response, angiogenesis, 
and cancer growth (Theoharides and 
Conti, 2004). In fact, elevation of serum 
IL-6 in response to acute stress is entire-
ly mast cell-dependent (Huang et al., 
2003). Such selective release of mast-
cell mediators is often associated with 
ultrastructural alterations of their elec-
tron dense granular core — which are 
indicative of secretion — but without 
degranulation; this process is termed 
“activation” (Kandere-Grzybowska et 
al., 2003).
Skin innervation and neurogenic 
inflammation in stress response
The skin is highly innervated by a pleni-
tude of nerve fiber subpopulations, 
each carrying one or more neuronal 
mediators into the skin, which may be 
released upon central or peripheral 
stimulation (Peters et al., 2005). Skin 
nerve fibers also carry neuronal media-
tors, and the involvement of such neu-
ronal mediators — that is, the sensory 
neuropeptide SP (Paus et al., 1994) or 
the neurotrophin NGF — in the stress 
response has recently been acknowl-
edged (Peters et al., 2004).
Stress and the skin: working concepts
Established mouse models for inves-
tigation of the impact of psychologi-
cal stress on skin homeostasis are now 
available (Arck et al., 2001; Arck et 
al., 2003b). In one model, exposure to 
sound stress severely impairs mecha-
nisms of immune tolerance in various 
organs — for example, the Th1/Th2 
cytokine ratio, the expression of indole-
amine 2,3-dioxygenase, and the pres-
ence of CD4+CD25bright regulatory 
T cells (Blois et al., 2005). Further, leu-
kocyte function-associated antigen-1 
acts as a key peripheral blood marker 
for stress perception (Blois et al., 2005). 
This stress model is now widely used in 
neuroimmunological stress research, for 
example, to evaluate the effects of stress 
on bronchial hyperreactivity (Joachim 
et al., 2004) or on experimental colitis 
(Qiu et al., 1999). Using this model, 
it has been shown that stress exerts 
severe skin inflammation, affecting, for 
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instance, hair growth or the aggravation 
of experimental atopic dermatitis (Arck 
et al., 2003b; Peters et al., 2005). In a 
distinct, complementary rodent stress 
model, mice exposed to foot shock 
showed similar inhibition of hair growth 
in a similar way (Aoki et al., 2003).
In this accepted murine model of 
chronic “psychological” stress, expo-
sure to sound stress induces neurogenic 
skin inflammation characterized by 
increased NGF expression, upregulated 
perifollicular mast-cell degranulation, 
and perifollicular accumulation of anti-
gen-presenting cells, thus inhibiting 
hair growth by downregulating prolifer-
ation and upregulating apoptosis of hair 
follicle keratinocytes and by prema-
turely triggering hair follicle regression 
(catagen) (Arck et al., 2001; Peters et 
al., 2004). In the absence of functional 
mast cells or the neurokinin-1 receptor 
(Arck et al., 2005), and in the presence 
of neurokinin-1 receptor blockers (Arck 
et al., 2003b) or NGF-neutralizing anti-
bodies (Peters et al., 2004), exposure to 
sound stress fails to induce premature 
catagen entry, neurogenic skin inflam-
mation, and keratinocyte apoptosis. 
Intriguingly, stress exposure is associ-
ated with an upregulation not only in 
the number of intracutaneous SP+ nerve 
fibers, but also in SP immunoreactivity 
in dorsal root ganglia, as measured by 
retrograde tracing (Peters et al., 2004). 
Therefore, in this model, psychological 
stress activates a defined, hierarchically 
organized cascade of events in which 
NGF, SP, and mast cells play key roles. 
It remains to be determined whether 
CRH and/or ACTH reside upstream of 
NGF and/or SP.
The obvious question raised by these 
findings is how NGF and/or SP trigger 
or exacerbate deleterious inflamma-
tory events such as mast-cell activa-
tion or migration of antigen-presenting 
cells. Indeed, NGF directly stimulates 
activation of mast cells via functional 
neurotrophin receptors (Marshall et 
al., 1999), thus aggravating cutaneous 
neurogenic inflammation (Figure 2). 
Furthermore, in response to stress, mast 
cells may secrete proteinases such as 
tryptase and trypsin, which may sub-
sequently trigger additional cytokine 
release, cell migration, recruitment of 
leukocytes, and endothelial-cell acti-
vation (Steinhoff et al., 2000). Tryptase-
releasing mast cells can be found in 
close proximity to proteinase-activated 
receptor-2-expressing cells such as 
keratinocytes, dermal endothelial cells, 
and C fibers during inflammation.
These mechanisms probably act 
synergistically with NGF and SP to 
upregulate the neurogenic inflamma-
tion cascade. Moreover, the release 
of other neuropeptides — for exam-
ple, calcitonin gene-related peptide 
— may also be upregulated upon stress 
exposure (A Kuhlmei and P C Arck, 
unpublished observations), and this 
may result in subsequent proteinase-
activated receptor activation. Further, 
NGF is also implicated in the HPA 
axis (Scaccianoce et al., 1993). Hence, 
stress-induced neurogenic skin inflam-
mation may affect the HPA axis, thus 
affecting behavior or leading to even 
higher stress perception (Figure 1).
Perspectives: long-term damage of skin 
stem cells induced by stress?
Future research in the analysis of cuta-
neous stress response patterns should 
focus on crucial skin-cell populations 
that may be especially vulnerable 
to stress and that are critical to skin 
homeostasis and regeneration. One 
such cell population could be hair 
follicle epithelial stem cells, which 
are vital for maintenance and cyclic 
renewal of the pilosebaceous appa-
ratus (Panteleyev et al., 2001). Sound 
stress in mice upregulates the number 
of apoptotic cells in the bulge region 
of the hair follicle and attracts dense, 
potentially autodestructive perifol-
licular cell infiltrates consisting mainly 
of activated macrophages to this cru-
cial epithelial stem-cell region of the 
hair follicle (Arck et al., 2001; Arck 
et al., 2003). This places the hair fol-
licle at risk of irreversible damage by 
induction of programmed hair follicle 
organ deletion.
Theoretically, stress may also affect 
melanocyte stem cells — for example, 
in the hair follicle during premature, 
“stress-induced” graying or alopecia 
areata, or in the epidermis during viti-
ligo, a depigmentation disorder that, in 
a minority of patients, may be triggered 
or aggravated by acute psychoemotion-
al stress (Nishimura et al., 2005).
Perspectives: from bench to bedside
No specific pharmacological interven-
tions are as yet available to prevent or 
treat stress-triggered skin disorders in 
humans. However, based on the wealth 
of data that has recently accumulated 
in this field, reasonable pharmacologi-
cal treatment options are slowly com-
ing into sight.
Abrogation of mast-cell activation 
seems to be a promising approach in 
this endeavor, but to date, few if any 
clinically available molecules can 
effectively inhibit mast-cell activation. 
Disodium cromoglycate was shown 
to inhibit rodent mast cells but was a 
very weak inhibitor of mast-cell cyto-
kine release (Kempuraj et al., 2002). 
Increasing recent evidence indicates 
that certain flavonols, such as querce-
tin, are powerful inhibitors of both pre-
stored and newly synthesized media-
tors from human mast cells. The combi-
nation of such flavonoids with proteo-
glycans, such as chondroitin sulphate, 
appears to provide synergistic efficacy 
by inhibiting both activation and secre-
tion of mast cells (Theoharides and 
Bielory, 2004). Appropriate CRH-R 
antagonists, when available, might also 
provide a unique therapeutic approach 
in skin conditions precipitated or wors-
ened by stress.
An effective therapeutic intervention 
— for example, to abrogate stress-trig-
gered telogen effluvium — would have 
to prolong the anagen phase of the hair 
cycle, thus preventing the premature 
onset of catagen, which forms the basis 
of stress-induced telogen effluvium. As 
external application of the potassium 
channel opener minoxidil to human 
scalp skin over many months can pro-
long anagen, it is interesting to note 
that topical minoxidil also very effec-
tively counteracts the stress-induced, 
hair growth-inhibitory changes in 
murine skin in vivo, including the inhi-
bition of mast-cell activation (Arck et 
al., 2003a).
Further, the prototypic stress-associ-
ated neuropeptide SP may be blocked 
by the application of a high-affinity neu-
rokinin-1 receptor antagonist (Arck et 
al., 2003b). Thus, neurokinin-1 receptor 
antagonists might be useful in alleviat-
ing stress-induced hair loss and skin 
inflammation. NGF receptor p75 antag-
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onists also deserve systematic explo-
ration as candidate “anti-stress” drugs 
in the treatment of stress-triggered or 
stress-aggravated skin disorders, such 
as psoriasis and stress-induced telo-
gen effluvium. However, one evidently 
must be very cautious in translating 
results from murine models to humans.
In conclusion, there is now solid 
evidence for the existence of both 
an intrafollicular equivalent of the 
HPA axis and a defined brain–skin 
axis, whose modulation by chronic 
psychological stress is of profound der-
matological interest. A new era in neu-
roimmunology must begin, and the pri-
mary goal is clearly to dissect proximal 
from distal mediators within the hier-
archy of factors released in the stress 
response. Only integrative approaches 
and interdisciplinary research will 
make this possible.
Lastly, dermatologists should become 
far more attentive to the effect of psy-
chological stress on skin disorders, not 
only for the benefit of their patients, 
but also because the skin serves as a 
very clinically relevant model system 
for exploring the neuroimmunology of 
peripheral and central stress responses.
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